1. Academic Validation
  2. 7-Ketocholesterol activates caspases-3/7, -8, and -12 in human microvascular endothelial cells in vitro

7-Ketocholesterol activates caspases-3/7, -8, and -12 in human microvascular endothelial cells in vitro

  • Microvasc Res. 2008 Apr;75(3):343-50. doi: 10.1016/j.mvr.2007.10.003.
Saurabh Luthra 1 Joyce Dong Ana L Gramajo Marilyn Chwa Dae W Kim Aneesh Neekhra Baruch D Kuppermann M Cristina Kenney
Affiliations

Affiliation

  • 1 Ophthalmology, Drishti Eye Centre, Dehradun, India.
Abstract

7-Ketocholesterol (7kCh) is a major oxysterol found associated with vascular diseases. Human microvascular endothelial cells (HMVECs) were cultured with different concentrations of 7kCh with and without inhibitors. Cell viabilities and Caspase activities were assessed. 7kCh caused loss of cell viability in a dose-dependent manner. Caspases-8, -12, and -3/7 but not caspase-9 were activated by 7kCh treatment. The 7kCh-induced Caspase-8 activity was blocked partially by pre-treatment with z-VAD-fmk and z-IETD-fmk, a Caspase-8 inhibitor. However, pre-treatment with z-ATAD-fmk, a caspase-12 inhibitor, followed by 7kCh exposure lead to significantly increased Caspase-8 activity. This suggests that Caspase-8 and caspase-12 pathways have unique inhibition patterns and that caspase-12 is likely not upstream and feeding into Caspase-8 but the pathways may function in parallel to each other. Caspase-3/7 activation was inhibited partially by low density lipoprotein (LDL), high density lipoprotein (HDL), z-VAD-fmk (pan-caspase inhibitor), and low doses (0.01 and 0.001 microM) of the Cholesterol lowering drug, simvastatin. However, only LDL partially protected against 7kCh-induced loss of cell viability suggesting that caspase-independent pathways also contributed to the cell loss and that protection from oxysterol damage may require inhibition of multiple pathways. Moreover, our data suggest that oxysterols such as 7kCh can damage HMVECs cells in part via caspase-dependent Apoptosis and may play a role in vascular and retinal diseases.

Figures
Products